scholarly article | Q13442814 |
P50 | author | Torleif Härd | Q5819684 |
Anatoly Dubnovitsky | Q58460772 | ||
Charles Eigenbrot | Q28037170 | ||
Mark Ultsch | Q28050881 | ||
P2093 | author name string | Lars Abrahmsén | |
P2860 | cites work | The stability and unfolding of an IgG binding protein based upon the B domain of protein A from Staphylococcus aureus probed by tryptophan substitution and fluorescence spectroscopy | Q72154686 |
Ligand-independent HER2/HER3/PI3K complex is disrupted by trastuzumab and is effectively inhibited by the PI3K inhibitor GDC-0941 | Q24321567 | ||
An affibody in complex with a target protein: Structure and coupled folding | Q27640525 | ||
Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab | Q27640593 | ||
The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors | Q27640631 | ||
Stabilization of a -hairpin in monomeric Alzheimer's amyloid- peptide inhibits amyloid formation | Q27650192 | ||
Variants of the antibody herceptin that interact with HER2 and VEGF at the antigen binding site | Q27654214 | ||
A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer | Q27851414 | ||
The ErbB signaling network: receptor heterodimerization in development and cancer | Q29617919 | ||
Studying excited states of proteins by NMR spectroscopy. | Q30329160 | ||
Selection and characterization of HER2/neu-binding affibody ligands | Q33203999 | ||
Tumor imaging using a picomolar affinity HER2 binding affibody molecule | Q33240101 | ||
Characterization of the dynamics of biomacromolecules using rotating-frame spin relaxation NMR spectroscopy | Q33242853 | ||
Structural basis for molecular recognition in an affibody:affibody complex | Q33245590 | ||
Engineered affinity proteins--generation and applications | Q33442549 | ||
Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex | Q34314489 | ||
Binding proteins selected from combinatorial libraries of an alpha-helical bacterial receptor domain | Q34435244 | ||
Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate | Q34880994 | ||
Affibody molecules for in vivo characterization of HER2-positive tumors by near-infrared imaging | Q36100348 | ||
Absence of a stable intermediate on the folding pathway of protein A. | Q36280502 | ||
Clinical activity of gemcitabine plus pertuzumab in platinum-resistant ovarian cancer, fallopian tube cancer, or primary peritoneal cancer | Q38419271 | ||
Strongly enhanced antitumor activity of trastuzumab and pertuzumab combination treatment on HER2-positive human xenograft tumor models | Q39771295 | ||
Dimeric HER2-specific affibody molecules inhibit proliferation of the SKBR-3 breast cancer cell line | Q39928084 | ||
Radionuclide therapy of HER2-positive microxenografts using a 177Lu-labeled HER2-specific Affibody molecule. | Q40158333 | ||
The application of circular dichroism to studies of protein folding and unfolding | Q41452511 | ||
Interaction of Alzheimer's A beta peptide with an engineered binding protein--thermodynamics and kinetics of coupled folding-binding | Q44381867 | ||
Parameters of helix-coil transition theory for alanine-based peptides of varying chain lengths in water | Q44844504 | ||
Conformational stabilization of an engineered binding protein. | Q51186216 | ||
Thermodynamics of folding, stabilization, and binding in an engineered protein--protein complex. | Q51618944 | ||
A synthetic IgG-binding domain based on staphylococcal protein A. | Q54412437 | ||
Mutational analysis of the interaction between staphylococcal protein A and human IgG1. | Q54656660 | ||
Molecular imaging of HER2-expressing malignant tumors in breast cancer patients using synthetic 111In- or 68Ga-labeled affibody molecules. | Q54673289 | ||
P433 | issue | 34 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 15039-44 | |
P577 | publication date | 2010-08-24 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Structural basis for high-affinity HER2 receptor binding by an engineered protein | |
P478 | volume | 107 |